Association of BDNF Val66Met Polymorphism with HPA and SAM Axis Reactivity to Psychological and Physical Stress
Overview
Authors
Affiliations
Background: Decreased expression of brain-derived neurotrophic factor (BDNF) is implicated in enhanced stress responses. The BDNF Val66Met polymorphism is associated with psychological changes; for example, carriers of the Met allele exhibit increased harm avoidance as well as a higher prevalence of depression and anxiety disorder.
Methods: To analyze the effects of BDNF Val66Met on stress responses, we tested 226 university students (88 women and 138 men) using a social stress procedure (Trier Social Stress Test [TSST]) and an electrical stimulation stress test. Stress indices were derived from repeated measurements of salivary α-amylase, salivary cortisol, heart rate, and psychological testing during the stress tests. All subjects were genotyped for the Val66Met polymorphism (G196A).
Results: A significant three-way interaction (time [3 levels] × BDNF [Val/Val, Val/Met, Met/Met]; P<0.05) was demonstrated that revealed different salivary cortisol responses in the TSST but not in electrical stimulation. Met/Met women had stronger cortisol responses than Val/Met and Val/Val individuals in the TSST. Met/Met men exhibited stronger salivary cortisol responses than Val/Met and Val/Val individuals in the TSST.
Conclusion: These results indicate that a common, functionally significant polymorphism in BDNF had different effects on hypothalamic-pituitary-adrenocortical axis reactivity but not on sympathetic adrenomedullary reactivity in TSST and electrical stimulation tests.
Rossi C, Amato A, Alesi M, Alioto A, Schiera G, Drid P PeerJ. 2024; 12:e16617.
PMID: 38390388 PMC: 10883150. DOI: 10.7717/peerj.16617.
Eslami M, Oryan S, Rahnema M, Bigdeli M Cell J. 2021; 23(3):303-312.
PMID: 34308573 PMC: 8286464. DOI: 10.22074/cellj.2021.7204.
Martens L, Herrmann L, Colic L, Li M, Richter A, Behnisch G Sci Rep. 2021; 11(1):6742.
PMID: 33762638 PMC: 7990923. DOI: 10.1038/s41598-021-86220-3.
Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review.
Zhao Y, Liang W, Cai F, Wu Q, Wang Y Front Endocrinol (Lausanne). 2021; 11:608886.
PMID: 33391186 PMC: 7774647. DOI: 10.3389/fendo.2020.608886.
Linz R, Puhlmann L, Apostolakou F, Mantzou E, Papassotiriou I, Chrousos G Neuropsychopharmacology. 2019; 44(10):1797-1804.
PMID: 30991416 PMC: 6785147. DOI: 10.1038/s41386-019-0391-y.